To investigate the value of tranexamic acid (TA) in reducing blood loss and blood transfusion after TKR and other clinical outcomes such as deep venous thrombosis (DVT), pulmonary embolism (PE), ischaemic heart diseases and mortality. A systematic review and meta-analysis of published randomised and quasi-randomised trials which used TA to reduce blood loss in knee arthroplasty was conducted. The data was evaluated using the generic evaluation tool designed by the Cochrane Bone, Joint and Muscle Trauma Group.Objectives
Methods
Traditional TKR designs exhibit abnormal and unpredictable kinematics: with posterior subluxation in extension and anterior slide with flexion. These can contribute to restricted knee flexion and reduced quadriceps efficiency. Newer designs attempt to provide “guided motion” with the aim of mimicking normal knee kinematics. The Journey (Smith & Nephew) BCS TKR incorporates both an anterior and a posterior cam/post mechanism while Triathlon PS TKR (Stryker) incorporates a posterior cam/post mechanism. This study compares the in-vivo kinematics of these two designs and compares it with normal knee. Knee kinematics of 10 patients with Journey-BCS TKR and 11 patients with Triathlon PS TKR; all with excellent clinical outcome (average age: 65) were analysed. Patients underwent fluoroscopic assessment of the knee during a step-up and deep knee bend exercise. 2D fluoroscopic images were recorded. Data was analysed for patella tendon angle (PTA) and contact points using a 3D model fitting technique. This data was compared to normal knee kinematics (n=20).Introduction
Methods
We studied a series of Endo-Modell(r) rotating hinge knee replacements (RHKRs) to determine indications, implant survival and complication rates. Case notes were audited for a consecutive series of 129 implants performed between 08/12/2002 and 30/01/2009. Indication for use of RHKR was complex primary arthroplasty in 37.8% and revision in 62.2%. For primary arthroplasty with hinge prosthesis, commonest indications were: collateral ligament insufficiency (44.4%); advanced RA (13.9%); supracondylar fracture (5.6%). Indications for revision RHK arthroplasty were: aseptic loosening (40.4%); ligamentous or soft tissue failure (14.0%); periprosthetic fracture (7%); infection (51%). Infection was proven in 21% with 54% of patients requiring a one stage and 46% two stage revision. For revision cases, 74% of primary prostheses were cruciate retaining PFC (Depuy) and in 5%, the primary was itself an Endo-Modell(r) RHKR. Mean time from index to revision procedures was 6.7 years (range 1 year – 23 years). Complications were: deep infection (6.1%) and non-fatal PE (1%). None developed clinically detectable DVT. Transfusion was required in 29 cases (for such cases, an average 3 units was given). 30-day mortality was 1%. For the revision cases, the average length of hospital admission was 11 days. Mean duration of follow up was 45 months (with a minimum of 21 days and maximum of 92 months). During this time 2 RHKRs failed. A total of 7 patients died during the period from complications unrelated to their surgery. 31 cases were lost to follow up. We conclude that in this series of Endo-Modell(r) rotating hinge knee arthroplasties, results are comparable with similar revision procedures. There was a low rate of prosthesis failure, DVT and PE.
Mobile-bearing TKRs allow some axial rotation and may provide a more natural patellar movement. The aim was to compare patellar kinematics among the normal knee, fixed-bearing and mobile-bearing TKR. Optical computer navigation (Brainlab) was used to track the position of the femur, tibia and patella in 9 whole lower extremities (5 fresh cadavers) in the natural knee, in the same knee with the trial components of a posterior stabilised fixed-bearing TKR (FB) (Sigma PFC, Depuy) and a posterior stabilised mobile-bearing TKR (MB) (Sigma RP Stabilised). The patellae were not resurfaced. Values: mean+/−one standard deviation. Statistical analysis: two tailed paired Student's T-test.Introduction
Methods
Unicondylar knee replacements (UKR) may be more effective compared to Total knee replacements (TKR) in unicompartmental arthritis. We report patient outcomes & satisfaction data in an age matched cohort of patients with either a UKR or TKR. A single unit and single surgeon series of patients were recruited. Data was retrospectively collated for 68 patients with more than 24 months follow-up. UKR was undertaken in patients with isolated medial compartment osteoarthritis; stable ACL and less than grade 3 lateral patellar changes of the Outerbridge classification. TKR was undertaken for the rest. The patients were assessed with validated knee scores including the Total Knee Function Questionnaire (TKFQ) which focuses on recreational & sporting outcomes as well as activities of daily living (ADL). Patient satisfaction and perception of knee normality was measured on a visual analogue scale.Introduction
Method
To examine the short term patient assessed functional results of the Journey BCS ¯(Smith & Nephew) and Triathlon ¯(Stryker Orthopaedics, Mahwah, NJ) total knee replacements when compared to the Scorpio ¯(Stryker) total knee replacement using a multi-surgeon case control design in a single centre. From September 2006 to August 2008 a total of 135 Journey and 97 Triathlon total knee replacements (TKR) were performed. 105 patients with Journey and 90 patients with Triathlon implants were available for follow-up at a minimum of 1 year, with an average of 2 years. Age and sex matched controls were obtained from our pool of patients who had had Scorpio TKR's. The same surgeons using the same approach operated on patients in both groups. All implants were posterior stabilised and all underwent patella resurfacing. All patients were seen pre-operatively and followed up post operatively in a physiotherapist led joint review clinic to assess range of motion (ROM) as well as function using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Knee Score (OKS) and the High Activity Arthroplasty Score (HAAS - used post operatively only).OBJECTIVE
METHODS
Allogeneic blood transfusion is associated with complications and significant cost. The RD&E has looked at the use of autologous drains to decrease the frequency of allogeneic transfusion after our study of 100 cases showed an improved post-operative haemoglobin and reduced length of stay. In 2007 a protocol to identify those patients of increased need for an autologous drain was made using a study of 191 cases showed an average haemoglobin drop post-operatively of 3.05g/dl and average intra-operative blood loss of 285 ml. This protocol gave triggers for autologous drain use; preoperative haemoglobin of <13g/dl, intra-operative blood loss >400ml, tourniquet use, patient weight <50kg and patients refusing donated blood. In 2007-08, 65% of a further 275 cases analysed met the triggers for use of an autologous system. The remaining patients received low vacuum drains. Of the 275 patients, only 2 (<1%) of those who did not fulfil the criteria for an autologous drain required allogeneic blood, compared with 43 patients (24%) of those deemed high risk of transfusion, and assigned autologous drains. The protocol was successful in identifying those patients who required additional support and expenditure to minimise allogeneic blood transfusion. Analysis of this data led to recommended changes to the protocol in order to maximise the efficiency of the autologous drain use. Due to the increased cost of autologous drains (£68) compared with the low vacuum systems (£32), and the cost of allogeneic units at £141, the expenditure per patient was calculated and shown to fall from £92 in 2007 to £78 in a further patient cohort in 2010. In conclusion, this protocol allows the clinician to appropriately target the use of the more expensive autologous drains to those of increased risk of transfusion. This helps to minimise unnecessary allogeneic transfusion, and this has been shown to be cost effective.
We prospectively reviewed 2440 Cemented Anantomical (side specific) AGC total knee replacements performed on 2074 patients between 2002 and 2008 in our unit. The surgery was performed by a number of surgeons, both Consultant and Trainee grades. 1357 underwent PCL sacrificing surgery with implantation of Posterior Stabilised Femoral Implant (Cam and Grove) and 1083 underwent PCL retaining surgery with implantation of a Non-Stabilised Femoral Implant. The mean age at date of surgery for Posterior Stabilised prosthesis was 69 years (range 23-94) and Non-Posterior Stabilised prosthesis was 70 (range 33-97) with no significant difference p< 0.05 (C.I 95%). Follow up at present mean 4 years (range 1-6 years). 11 patients underwent secondary patella resurfaced for anterior knee pain at a mean of 1.5 years following the index procedure (range 0.5-4.1 years) with 6 patients reporting a marked improvement in anterior knee pain post operatively. 3 patients underwent removal of patella buttons for symptomatic loosening at a mean of 2.7 years follow index procedure. A total of 17 patients underwent a revision of either tibial or femoral components (0.7%). Indications for revision were infection in 11 patients, gross instability in 1 patient, periprosthetic fracture in 1 patient, persistent stiffness in 1 patient. 3 patients underwent revision for symptomatic loosening of the tibial component at a mean of 2.9 years (range 1.1-4.0). These short to medium term results for the Anatomic AGC total knee replacement agree with published results from other centres.
Abstract. Patient Reported Outcome Measures (PROMs) can be completed using paper and postal services (pPROMS) or via computer, tablet or smartphone (ePROMs). We have investigated whether there are differences in scores depending on the method of PROMs acquisition for the Oxford Knee (OKS) and the EQ-5D scores, at one and two years post operatively. Patient demographics, mode of preferred data collection and pre-and post-operative PROMs for
